Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract

NCT01564017 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinoconjunctivitis

Interventions

BIOLOGICAL: Allergovac depot
BIOLOGICAL: Allergovac depot
BIOLOGICAL: Allergovac depot
BIOLOGICAL: Allergovac depot
BIOLOGICAL: Allergovac depot
BIOLOGICAL: Allergovac depot

Sponsor

Roxall Medicina España S.A